跳至主要内容
临床试验/EUCTR2018-001914-13-BE
EUCTR2018-001914-13-BE进行中(未招募)1 期

Clinical Trial to Evaluate the Efficacy and Safety of MACRORANGE® in Patients Suffering from Functional Constipation

Salsarulo Pharma0 个研究点目标入组 30 人开始时间: 2018年8月1日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Age of the patients: = 18 years of age;
  • Male and female patients;
  • Stool frequency < 3 per week;
  • Functional constipation as defined in constipation module of ROME III
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 22
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • Irritable Bowel Syndrome (IBS specifically type C);
  • Hypersensitivity to the active substances or any excipients;
  • Organic inflammatory bowel disease (ulcerative rectocolitis, Crohn’s disease);
  • Toxic megacolon;
  • Gastrointestinal obstruction or subocclusive syndromes;
  • Allergic to aspartame;
  • Painful abdominal syndromes of undetermined origin;
  • Existing partial colectomy or bariatric surgery (gastric bypass type);
  • Presumed non-cooperativeness;
  • Concomitant treatment from start of wash-out period until discharge from the study with any medication that may alter the gastrointestinal motility (see section 6.2.2) in the opinion of the Investigator;
  • Legal incapacity;
  • Any clinical condition which does not justify study participation in the Investigator's opinion;
  • Participation = 8 weeks in a clinical trial;
  • Parallel participation in a clinical trial;
  • Repeated participation in this clinical trial.

研究者

发起方
Salsarulo Pharma

相似试验